These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. The optimism surrounding stereotactic body radiation therapy and immunomodulation. Tharmalingam H; Hoskin PJ Chin Clin Oncol; 2017 Sep; 6(Suppl 2):S9. PubMed ID: 28917247 [TBL] [Abstract][Full Text] [Related]
7. Abscopal Effect Following Immunotherapy and Combined Stereotactic Body Radiation Therapy in Recurrent Metastatic Head and Neck Squamous Cell Carcinoma: A Report of Two Cases and Literature Review. Choi JS; Sansoni ER; Lovin BD; Lindquist NR; Phan J; Mayo LL; Ferrarotto R; Su SY Ann Otol Rhinol Laryngol; 2020 May; 129(5):517-522. PubMed ID: 31875405 [TBL] [Abstract][Full Text] [Related]
8. Combining Radiotherapy and Immunotherapy in Metastatic Breast Cancer: Current Status and Future Directions. David S; Tan J; Siva S; Karroum L; Savas P; Loi S Biomedicines; 2022 Mar; 10(4):. PubMed ID: 35453571 [TBL] [Abstract][Full Text] [Related]
9. Report of an abscopal effect induced by stereotactic body radiotherapy and nivolumab in a patient with metastatic non-small cell lung cancer. Britschgi C; Riesterer O; Burger IA; Guckenberger M; Curioni-Fontecedro A Radiat Oncol; 2018 May; 13(1):102. PubMed ID: 29855323 [TBL] [Abstract][Full Text] [Related]
11. The emerging roles of stereotactic ablative radiotherapy for metastatic renal cell carcinoma. Cheung P; Thibault I; Bjarnason GA Curr Opin Support Palliat Care; 2014 Sep; 8(3):258-64. PubMed ID: 25090288 [TBL] [Abstract][Full Text] [Related]
12. Definitive Management of Oligometastatic Melanoma in a Murine Model Using Combined Ablative Radiation Therapy and Viral Immunotherapy. Blanchard M; Shim KG; Grams MP; Rajani K; Diaz RM; Furutani KM; Thompson J; Olivier KR; Park SS; Markovic SN; Pandha H; Melcher A; Harrington K; Zaidi S; Vile R Int J Radiat Oncol Biol Phys; 2015 Nov; 93(3):577-87. PubMed ID: 26461000 [TBL] [Abstract][Full Text] [Related]
13. A meta-analysis of the abscopal effect in preclinical models: Is the biologically effective dose a relevant physical trigger? Marconi R; Strolin S; Bossi G; Strigari L PLoS One; 2017; 12(2):e0171559. PubMed ID: 28222111 [TBL] [Abstract][Full Text] [Related]
14. PD-1 Restrains Radiotherapy-Induced Abscopal Effect. Park SS; Dong H; Liu X; Harrington SM; Krco CJ; Grams MP; Mansfield AS; Furutani KM; Olivier KR; Kwon ED Cancer Immunol Res; 2015 Jun; 3(6):610-9. PubMed ID: 25701325 [TBL] [Abstract][Full Text] [Related]
15. The dynamic duo: A narrative review on the synergy between stereotactic body radiotherapy and immunotherapy in lung cancer treatment (Review). Cheng SH; Tu KY; Lee HH Oncol Rep; 2024 Jul; 52(1):. PubMed ID: 38874014 [TBL] [Abstract][Full Text] [Related]
16. Stereotactic ablative radiotherapy for colorectal cancer liver metastasis. Wang H; Li X; Peng R; Wang Y; Wang J Semin Cancer Biol; 2021 Jun; 71():21-32. PubMed ID: 32629077 [TBL] [Abstract][Full Text] [Related]
17. Review of the mechanisms involved in the abscopal effect and future directions with a focus on thymic carcinoma. Lesueur P; Chevalier F; Stefan D; Habrand JL; Lerouge D; Gervais R Tumori; 2017 May; 103(3):217-222. PubMed ID: 28291902 [TBL] [Abstract][Full Text] [Related]
18. Abscopal effect in pulmonary carcinoid tumor following ablative stereotactic body radiation therapy: a case report. Kareff SA; Lischalk JW; Krochmal R; Kim C J Med Case Rep; 2020 Oct; 14(1):177. PubMed ID: 33010806 [TBL] [Abstract][Full Text] [Related]